Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clevidipine in the Treatment of Patients With Severe Hypertension

Study:

Evaluation of the Effect of Ultrashort-Acting Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)

Rationale:

n/a

Purpose:

The purpose of this study is to determine the safety of clevidipine for treating severely elevated blood pressure in patients with or without major organ injury, especially with respect to controlled dose adjustment to desired effect and continuous infusion.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Hypertension Drug: Clevidipine Phase 3

Verified by The Medicines Company October, 2008

Sponsored by: The Medicines Company
Information provided by: The Medicines Company
ClinicalTrials.gov identifier: NCT00369837

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment

The Cleveland Clinic
Cleveland, Ohio 44195
United States

Charles V Pollack, MA MD FACEP., Principal Investigator
Frank Peacock, MD FACEP., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site